Grindr buys PrEP provider Freddie’s parent PurposeMed in $250m health push

Grindr wants to be more than an app for meeting people. On 30 September 2026, it signed an agreement to buy PurposeMed, the parent company of the HIV-prevention telehealth service Freddie, for $250m. If PurposeMed hits its 2027 targets, the price could rise by a further $70m.

Executives described it, according to Fierce Healthcare, as the company’s “first major acquisition” since its founding, and a “significant step in building out the Global Gayborhood”, a phrase the company uses for its ambitions beyond dating.

The Grindr–PurposeMed deal terms

The base price is split between $190m in cash and $60m in Grindr shares. Grindr’s regulatory filing puts the share component at 3,851,684 shares, valued at $15.58 each using the 15-day volume-weighted average price to 29 September, with a 12-month lock-up after closing.

The earn-out of up to $70m in cash depends on PurposeMed meeting financial targets for the year ending 31 December 2027 and would be paid in 2028. Grindr expects the deal to close in the fourth quarter of 2026, subject to conditions including a pre-closing restructuring of PurposeMed and NYSE approval for the new shares. Either side can walk away if it has not closed by 30 December 2026.

What Freddie does

Freddie provides PrEP, medication taken to prevent HIV, through telehealth consultations. It was founded in Canada in 2020, now serves patients in all 50 US states, and says it has helped more than 55,000 patients in Canada and the US access PrEP. Fierce Healthcare reports that PurposeMed expects more than $80m in revenue and more than $10m in adjusted EBITDA in 2026.

“We built Freddie to make HIV prevention simple and accessible for everyone who needs it,” said Husein Moloo, its co-founder and chief executive.

Grindr Health: what changes inside the app

Freddie will be combined with Woodwork, Grindr’s existing performance-medication service, into a single Grindr Health offering. Taking part will be voluntary for both Grindr users and Freddie patients. Grindr has set a goal of connecting 10 million LGBTQ+ people worldwide to HIV prevention through the app by 2028.

George Arison, Grindr’s chief executive and chair, framed the purchase as a public-health mission. “New infections should be close to zero, and that is what we are striving to achieve,” he said. “The challenge is connecting people to PrEP and helping them stay on it.”

Why a dating app is buying a healthcare company

The logic is about reach. Fierce Healthcare cites estimates that about 650,000 people in the US are on PrEP, against some 2.2 million who could benefit, and reports that most eligible gay and bisexual men are still not taking it. Grindr’s bet is that an app those men already open is the most direct route to them. For investors, health services offer a revenue line less exposed to the subscription fatigue that is squeezing Tinder and Bumble.

It also raises an obvious question about trust. Grindr’s history with health data is not spotless: earlier in September, it agreed to pay £26m to settle a UK group action over alleged sharing of users’ sensitive data, including HIV status, before 2020, without admitting liability, according to its SEC filing. Running a medical service inside a dating app will require users to believe that their health information stays where it belongs, and keeping Grindr Health voluntary is a sensible first step.

For how the core app performs, including its privacy settings, see our Grindr review.

Sources

• Grindr acquires HIV prevention telehealth provider for $250M (Fierce Healthcare, 2 October 2026)
• Grindr Inc. Form 8-K on the PurposeMed securities purchase agreement (via Stock Titan, 30 September 2026)
• Grindr Inc. Form 8-K on the UK settlement (US Securities and Exchange Commission, 4 September 2026)